Glufosfamide With or Without Hydration in Treating Patients With Advanced Pancreatic Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

December 31, 1999

Primary Completion Date

March 31, 2001

Conditions
Pancreatic Cancer
Interventions
DRUG

glufosfamide

Trial Locations (15)

13385

CHU de la Timone, Marseille

31096

Rambam Medical Center, Haifa

35064

Centre Eugene Marquis, Rennes

69373

Centre Leon Berard, Lyon

76038

Centre Henri Becquerel, Rouen

DK-2730

Herlev Hospital - University Hospital of Copenhagen, Herlev

D-20246

Universitats-Krankenhaus Eppendorf, Hamburg

D-30625

Medizinische Hochschule Hannover, Hanover

D-80639

Haemato-Onkologische Praxis und Tagesklinik, Munich

D-90419

Klinikum Nurnberg, Nuremberg

GR-45110

University of Ioannina, Ioannina

1117 MB

Academisch Ziekenhuis der Vrije Universiteit, Amsterdam

CH-3010

Inselspital, Bern, Bern

CH-1011

Centre Hospitalier Universitaire Vaudois, Lausanne

CH-9007

Kantonsspital - Saint Gallen, Sankt Gallen

All Listed Sponsors
lead

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK

NCT00005053 - Glufosfamide With or Without Hydration in Treating Patients With Advanced Pancreatic Cancer | Biotech Hunter | Biotech Hunter